Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...

Of the hundreds of millions of people living with diabetes, most liv. Dexcom wants to make sure they have tools to manage it.

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

SINGAPORE: The Maritime and Port Authority of Singapore (MPA) has renewed its collaboration with  CMA CGM Group, marking a significant step towards advancing s ...

A survey conducted by the continuous glucose monitor maker Dexcom found that just over half of healthcare providers ranked technology and education as having larger impacts when it comes | Dexcom ...

Stock indexes today are moderately higher ahead of the results of today’s FOMC meeting.  A rebound in the Magnificent Seven stocks today from Tuesday’s selloff supports gains in the broader market. ...

The new patents focus on Welldoc's unique approach to combining dense, sensor-based data specifically collected from Continuous Glucose Monitors (CGM), with AI to predict future engagement levels, ...

Dexcom (Nadsaq:DXCM) announced today that it launched a new multi-region report evaluating type 2 diabetes treatments.

The Diabetic Care Devices Market is projected to grow from $16.6 billion in 2024 to $26.8 billion by 2029, at a CAGR of 10.1%. This report provides a comprehensive analysis of diabetes monitoring ...

The major shipping lines (that report on – and have so far published – their financial figures) have recorded a combined 2024 ...

HCPs see CGM as the 'standard of care': Half of all HCPs felt CGM should be the standard of care for people with Type 2 diabetes whether they were using insulin to manage the condition or not. 96% of ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...